Indication

Proteus pyelonephritis

Proteus pyelonephritis is an upper urinary tract infection characterized by bacterial inflammation of the renal parenchyma and renal pelvis caused by species of the Gram-negative genus *Proteus*, most commonly *Proteus mirabilis*. Read more about Proteus pyelonephritis

19 drugs 16 manufacturers

Advertisement

Drugs that treat it

Common Proteus pyelonephritis therapies.

Showing 19–19 of 19 drugs

CEFEPIME HCL

BETA-LACTAMS·FEBRILE NEUTROPENIC PATIENT PRESUMED INFECTION TREATMENT·+26
Hikma Pharmaceuticals USA
Filter & compare in the drug finder →Opens the drug finder with Proteus pyelonephritis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Proteus pyelonephritis.

Proteus pyelonephritis is an upper urinary tract infection characterized by bacterial inflammation of the renal parenchyma and renal pelvis caused by species of the Gram-negative genus *Proteus*, most commonly *Proteus mirabilis*.

It disproportionately affects elderly individuals, patients with indwelling urinary catheters, and those with structural or functional urinary tract abnormalities.

Clinically marked by fever, flank pain, costovertebral angle tenderness, and pyuria, its hallmark pathophysiology involves potent bacterial urease activity that hydrolyzes urea into ammonia and carbon dioxide.

This process markedly alkalinizes the urine, causing mucosal damage and precipitating magnesium ammonium phosphate and calcium phosphate crystals, which predisposes patients to struvite staghorn calculi, urinary obstruction, and renal parenchymal scarring.

Personalize your experience

Follow Proteus pyelonephritis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it